Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Open Access
- 7 January 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 517 (7534), 381-385
- https://doi.org/10.1038/nature14053
Abstract
Despite receiving antiretroviral therapy, most patients with HIV still have latent reservoirs of the virus; here, these reservoirs are shown to be dominated by viruses with cytotoxic T lymphocyte escape mutations, with potential implications for the development of therapeutic vaccines. Antiretroviral therapy does not cure HIV-1 infection: despite drug treatment, most patients still have latent reservoirs of the virus. This study of immune cells isolated from 30 HIV-1-infected patients who had been on antiretroviral therapy for at least two years and had maintained undetectable plasma HIV-1 RNA levels, shows that these viral reservoirs are dominated by viruses with cytotoxic T lymphocyte escape mutations. This finding implies that future directions in therapeutic vaccine design may need to focus on boosting broad cytotoxic T lymphocyte responses. Despite antiretroviral therapy (ART), human immunodeficiency virus (HIV)-1 persists in a stable latent reservoir1,2, primarily in resting memory CD4+ T cells3,4. This reservoir presents a major barrier to the cure of HIV-1 infection. To purge the reservoir, pharmacological reactivation of latent HIV-1 has been proposed5 and tested both in vitro and in vivo6,7,8. A key remaining question is whether virus-specific immune mechanisms, including cytotoxic T lymphocytes (CTLs), can clear infected cells in ART-treated patients after latency is reversed. Here we show that there is a striking all or none pattern for CTL escape mutations in HIV-1 Gag epitopes. Unless ART is started early, the vast majority (>98%) of latent viruses carry CTL escape mutations that render infected cells insensitive to CTLs directed at common epitopes. To solve this problem, we identified CTLs that could recognize epitopes from latent HIV-1 that were unmutated in every chronically infected patient tested. Upon stimulation, these CTLs eliminated target cells infected with autologous virus derived from the latent reservoir, both in vitro and in patient-derived humanized mice. The predominance of CTL-resistant viruses in the latent reservoir poses a major challenge to viral eradication. Our results demonstrate that chronically infected patients retain a broad-spectrum viral-specific CTL response and that appropriate boosting of this response may be required for the elimination of the latent reservoir.Keywords
This publication has 34 references indexed in Scilit:
- Cytomegalovirus Vectors Violate CD8 + T Cell Epitope Recognition ParadigmsScience, 2013
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus ReactivationImmunity, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- FLASH: fast length adjustment of short reads to improve genome assembliesBioinformatics, 2011
- The immune response during acute HIV-1 infection: clues for vaccine developmentNature Reviews Immunology, 2009
- The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infectionThe Journal of Experimental Medicine, 2009
- The Challenge of Finding a Cure for HIV InfectionScience, 2009
- Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected CellsOnline Journal of Public Health Informatics, 2009
- Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic AcidAIDS Research and Human Retroviruses, 2009
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997